Outcomes of Third-Line Trastuzumab Deruxtecan in a Patient with De Novo Stage 4 HER2-Positive Gastric Adenocarcinoma with Enteroblastic Differentiation: A Case Report

This case report describes the treatment of a patient diagnosed with de novo stage 4 human epidermal growth factor 2 (HER2)-positive gastric adenocarcinoma with enteroblastic differentiation (GAED), a rare and aggressive form of gastric cancer characterized by a tubulopapillary growth pattern and en...

Descripción completa

Detalles Bibliográficos
Autor principal: Ngan, Roger Kai-Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533056/
https://www.ncbi.nlm.nih.gov/pubmed/37763255
http://dx.doi.org/10.3390/life13091851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533056/
https://www.ncbi.nlm.nih.gov/pubmed/37763255
http://dx.doi.org/10.3390/life13091851

Ejemplares similares